LNA Santé SA (EPA:LNA)
France · Delayed Price · Currency is EUR 24.70
-2.40 (-8.86%)
Oct 2, 2026, 5:35 PM CET
LNA Santé Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 950.25 | 912.67 | 806.6 | 736.09 | 728.22 | 689.49 | |
Revenue Growth | 10.06% | 13.15% | 9.58% | 1.08% | 5.62% | 20.14% |
Cost of Revenue | 686.69 | 661.15 | 550.83 | 495 | 499.3 | 460.04 |
Gross Profit | 263.56 | 251.52 | 255.77 | 241.09 | 228.93 | 229.46 |
Selling, General & Admin | 66.28 | 63.99 | 82.93 | 75.91 | 73.36 | 81.67 |
Other Operating Expenses | 35.28 | 29.04 | 27.54 | 20.6 | 28.32 | 12.12 |
Operating Expenses | 188.33 | 178.61 | 192.77 | 179.33 | 180.04 | 170.68 |
Operating Income | 75.23 | 72.91 | 63 | 61.76 | 48.89 | 58.78 |
Interest Expense | -30.19 | -29.74 | -29.4 | -27.27 | -21.07 | -20.01 |
Interest & Investment Income | 0.22 | 0.23 | 0.4 | 0.13 | 0.21 | 0.21 |
Earnings From Equity Investments | 0.74 | -0.05 | -0.17 | -0.07 | 1.07 | 2.32 |
Currency Exchange Gain (Loss) | 0.19 | 0.19 | 0.21 | 1.06 | -0.23 | - |
Other Non Operating Income (Expenses) | 0.29 | 0.4 | 0.5 | 0.42 | 0.48 | 0.24 |
EBT Excluding Unusual Items | 46.47 | 43.95 | 34.54 | 36.03 | 29.36 | 41.54 |
Merger & Restructuring Charges | -0.93 | -0.46 | -0.89 | -0.19 | -0.41 | -2.34 |
Impairment of Goodwill | -5.65 | -5.65 | -1.85 | -1.27 | -2.41 | -0.6 |
Gain (Loss) on Sale of Assets | 0 | -0.06 | 0.69 | -0.04 | -0.28 | -0.03 |
Asset Writedown | 2 | 2 | -3.79 | - | - | - |
Other Unusual Items | - | - | 5.25 | 1.51 | 17.99 | - |
Pretax Income | 41.9 | 39.77 | 33.95 | 37.25 | 44.25 | 38.57 |
Income Tax Expense | 14.92 | 14.06 | 11.02 | 13.02 | 15.91 | 14.59 |
Earnings From Continuing Operations | 26.98 | 25.72 | 22.92 | 24.23 | 28.33 | 23.99 |
Minority Interest in Earnings | -1.64 | -1.57 | -1.11 | -0.82 | -2.52 | -0.48 |
Net Income | 25.34 | 24.15 | 21.82 | 23.41 | 25.81 | 23.51 |
Net Income to Common | 25.34 | 24.15 | 21.82 | 23.41 | 25.81 | 23.51 |
Net Income Growth | 22.02% | 10.68% | -6.80% | -9.31% | 9.80% | 201.14% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | 0.33% | 0.33% | 0.03% | -1.32% | 7.93% | 0.17% |
EPS (Basic) | 2.47 | 2.35 | 2.13 | 2.29 | 2.49 | 2.45 |
EPS (Diluted) | 2.47 | 2.35 | 2.13 | 2.29 | 2.49 | 2.45 |
EPS Growth | 21.62% | 10.31% | -6.83% | -8.10% | 1.60% | 201.04% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 88.66 | 88.29 | 99.62 | 85.98 | 91.24 | 69.68 |
Free Cash Flow Per Share | 8.63 | 8.61 | 9.74 | 8.41 | 8.81 | 7.26 |
Dividend Per Share | 0.950 | 0.950 | 0.650 | 0.600 | 0.500 | 0.430 |
Dividend Growth | 46.15% | 46.15% | 8.33% | 20.00% | 16.28% | 115.00% |
Gross Margin | 27.74% | 27.56% | 31.71% | 32.75% | 31.44% | 33.28% |
Operating Margin | 7.92% | 7.99% | 7.81% | 8.39% | 6.71% | 8.53% |
Profit Margin | 2.67% | 2.65% | 2.71% | 3.18% | 3.55% | 3.41% |
Free Cash Flow Margin | 9.33% | 9.67% | 12.35% | 11.68% | 12.53% | 10.11% |
EBITDA | 99.33 | 95.62 | 91.63 | 83.78 | 76 | 83.78 |
EBITDA Margin | 10.45% | 10.48% | 11.36% | 11.38% | 10.44% | 12.15% |
D&A For EBITDA | 24.1 | 22.71 | 28.63 | 22.02 | 27.11 | 25 |
EBIT | 75.23 | 72.91 | 63 | 61.76 | 48.89 | 58.78 |
EBIT Margin | 7.92% | 7.99% | 7.81% | 8.39% | 6.71% | 8.53% |
Effective Tax Rate | 35.60% | 35.34% | 32.47% | 34.96% | 35.97% | 37.81% |